As part of its ongoing efforts to expand its international market reach and strengthen its presence in the global animal health industry, PT Sanbio Laboratories participated in The 26th International Exhibition for the Management & Production of Poultry, Livestock & Fish (AGRENA 2026), held in Cairo, Egypt, from October 15–17, 2026.
This participation represents a strategic step for PT Sanbio Laboratories in showcasing its capabilities as an Indonesian animal vaccine manufacturer while expanding its network of connections with stakeholders across the international poultry, livestock, and animal health industries.
AGRENA is an international exhibition focused on the management and production of poultry, livestock, and fish. The event provides a platform for industry stakeholders to explore technological developments, products, and solutions that support greater efficiency and productivity across the livestock sector.
Through its participation in AGRENA 2026, PT Sanbio Laboratories seeks to expand its professional network and explore potential collaboration opportunities with various industry stakeholders. The exhibition also provides an opportunity to enhance the company's visibility and introduce the potential of Sanbio's poultry vaccine portfolio to a broader international audience.
Amid the continued evolution of the poultry industry, flock health and disease prevention remain essential to sustainable livestock production. Strengthening industry partnerships and improving access to appropriate animal health solutions are therefore important elements in supporting the long-term development of the livestock sector.
PT Sanbio Laboratories' participation in AGRENA 2026 marks another step in the company's ongoing journey toward growth and international business expansion. Through its involvement in international exhibitions, Sanbio remains committed to building broader connections, exploring new opportunities, and strengthening its role in the animal health industry.
This initiative aligns with the company's commitment to continued growth and the development of animal vaccine solutions that support livestock health and the advancement of the livestock industry.
From Indonesia to the world, PT Sanbio Laboratories continues to expand opportunities, strengthen partnerships, and contribute to a better future for the global animal health industry.